253 related articles for article (PubMed ID: 14963659)
1. [Contrast-enhanced sonography using Levovist is decisive for staging and therapeutic schedule in hepatocellular carcinoma].
von Herbay A; Donner A; Jung G; Vogt C; Häussinger D
Med Klin (Munich); 2004 Feb; 99(2):89-92. PubMed ID: 14963659
[TBL] [Abstract][Full Text] [Related]
2. Characterization and detection of hepatocellular carcinoma (HCC): comparison of the ultrasound contrast agents SonoVue (BR 1) and Levovist (SH U 508A)--comparison of SonoVue and Levovist in HCC.
von Herbay A; Haeussinger D; Gregor M; Vogt C
Ultraschall Med; 2007 Apr; 28(2):168-75. PubMed ID: 17447216
[TBL] [Abstract][Full Text] [Related]
3. [Differential diagnosis of focal liver lesions using contrast-enhanced MRI with SHU 555 A in comparison with unenhanced MRI and multidetector spiral-CT].
Jung G; Poll L; Cohnen M; Saleh A; Vogler H; Wettstein M; Willers R; Mödder U; Koch JA
Rofo; 2005 Nov; 177(11):1571-7. PubMed ID: 16302139
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
Kim YK; Kwak HS; Han YM; Kim CS
J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
[TBL] [Abstract][Full Text] [Related]
5. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US.
Vogl TJ; Schwarz W; Blume S; Pietsch M; Shamsi K; Franz M; Lobeck H; Balzer T; del Tredici K; Neuhaus P; Felix R; Hammerstingl RM
Eur Radiol; 2003 Feb; 13(2):262-72. PubMed ID: 12598989
[TBL] [Abstract][Full Text] [Related]
6. Comparing Levovist-enhanced pulse inversion harmonic imaging and ferumoxides-enhanced MR imaging of hepatic metastases.
Del Frate C; Zuiani C; Londero V; Como G; Bazzocchi M; Mortele K; Ros PR
AJR Am J Roentgenol; 2003 May; 180(5):1339-46. PubMed ID: 12704048
[TBL] [Abstract][Full Text] [Related]
7. Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.
Kim SH; Choi D; Kim SH; Lim JH; Lee WJ; Kim MJ; Lim HK; Lee SJ
AJR Am J Roentgenol; 2005 Apr; 184(4):1069-76. PubMed ID: 15788575
[TBL] [Abstract][Full Text] [Related]
8. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
9. Preoperative depiction of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus triple-phase helical CT.
Kang BK; Lim JH; Kim SH; Choi D; Lim HK; Lee WJ; Lee SJ
Radiology; 2003 Jan; 226(1):79-85. PubMed ID: 12511672
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.
Arita J; Takahashi M; Hata S; Shindoh J; Beck Y; Sugawara Y; Hasegawa K; Kokudo N
Ann Surg; 2011 Dec; 254(6):992-9. PubMed ID: 21694582
[TBL] [Abstract][Full Text] [Related]
11. [Detection of liver lesions: magnetic resonance tomography using superparamagnetic iron particles (AMI-25, endorem) as a contrast medium in comparison with ultrasound diagnosis, computerized tomography and CT portography].
Pleger B; Beyer HK; Laufer U
Rontgenpraxis; 2001; 53(6):245-9. PubMed ID: 11402872
[No Abstract] [Full Text] [Related]
12. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
[TBL] [Abstract][Full Text] [Related]
13. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of hepatocellular carcinoma using contrast media.
Kim MJ; Choi JY; Chung YE; Choi SY
Oncology; 2008; 75 Suppl 1():72-82. PubMed ID: 19092275
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the diagnostic efficacy of SPIO enhanced MRI in patients with focal hepatic lesions--comparison with CECT and CTAP].
Kasugai H; Katayama N; Sakai S; Yamakawa T
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2311-5. PubMed ID: 12484062
[TBL] [Abstract][Full Text] [Related]
16. Value of liver parenchymal phase contrast-enhanced sonography to diagnose premalignant and borderline lesions and overt hepatocellular carcinoma.
Inoue T; Kudo M; Maenishi O; Komuta M; Nakashima O; Kojiro M; Maekawa K
AJR Am J Roentgenol; 2009 Mar; 192(3):698-705. PubMed ID: 19234266
[TBL] [Abstract][Full Text] [Related]
17. Application of percutaneous ultrasound-guided treatment for ultrasonically invisible hypervascular hepatocellular carcinoma using microbubble contrast agent.
Maruyama H; Kobayashi S; Yoshizumi H; Okugawa H; Akiike T; Yukisawa S; Fukuda H; Matsutani S; Ebara M; Saisho H
Clin Radiol; 2007 Jul; 62(7):668-75. PubMed ID: 17556036
[TBL] [Abstract][Full Text] [Related]
18. Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity.
Kato H; Kanematsu M; Kondo H; Goshima S; Matsuo M; Hoshi H; Moriyama N
J Magn Reson Imaging; 2004 Jan; 19(1):76-81. PubMed ID: 14696223
[TBL] [Abstract][Full Text] [Related]
19. [New super-paramagnetic iron particles for MRI. Phase II study of malignant liver tumors].
Daldrup HE; Reimer P; Rummeny EJ; Tombach B; Berns T; Balzer T; Schimpfky C; Peters PE
Radiologe; 1995 Aug; 35(8):486-93. PubMed ID: 7568792
[TBL] [Abstract][Full Text] [Related]
20. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C
Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
